Sonia Rao - Peptides Today News and Research

Unmasking the Cathelicidin-PAD4 Axis in the Agony of IBD: A Vital Report on Hope for Clinical Viability.

Sonia Rao December 18, 2025 No Comments

Inflammatory Bowel Disease, commonly referred to as IBD, includes Crohn’s disease and ulcerative colitis and affects millions of people worldwide. Despite advances in biologics and small-molecule drugs, many patients fail…

Biocon’s Strategic Consolidation: A Bold Play in the ‘Diabesity’ Market

Sonia Rao December 18, 2025 No Comments

As the pharmaceutical landscape shifts, Biocon is making decisive moves to solidify its leadership in the diabesity sector. The announced $5.5 billion merger of its biosimilars division, Biocon Biologics, back into…

Analyzing Unregulated Oral Peptides in the Wellness sector.

Sonia Rao December 17, 2025 No Comments

Unregulated oral peptides are becoming increasingly visible in the wellness industry, often promoted as convenient, needle free solutions for daily health routines. The recent announcement from Instamed Philippines about oral…

NX210c: A Preclinical Assessment of a Thrombospondin-Derived Peptide in Spinal Cord Injury

Sonia Rao December 13, 2025 No Comments

NX210c is emerging as one of the more scientifically grounded preclinical candidates in spinal cord injury research. Spinal cord injury, often referred to as SCI, remains a devastating neurological condition…

The Unseen Hand: How Mass Spectrometry Is Steering GLP-1 Therapeutics Toward Unprecedented Market Dominance

Sonia Rao December 11, 2025 No Comments

The global demand for every major GLP-1 therapeutic is rising faster than almost any other treatment class in metabolic medicine. The market is projected to grow from USD 53.46 billion…

PuraStat: Assessing Preclinical Evidence for Enhanced Mucosal Healing Post-Endoscopic Resection

Sonia Rao December 11, 2025 No Comments

The interest in PuraStat mucosal healing has grown quickly as gastroenterologists look for better ways to reduce delayed bleeding and improve recovery after advanced endoscopic procedures. Complex resections like EMR…

Deciphering Sapu Nano’s Deciparticle™ Platform: A Strategic Outlook on Hydrophobic Drug Delivery

Sonia Rao December 10, 2025 No Comments

Hydrophobic Drug Delivery remains one of the most persistent challenges in modern pharmaceutical development. Many promising therapeutic molecules such as macrolides, cyclic peptides, linear peptides, and polyketides demonstrate strong bioactivity,…

Assessing Animate Biosciences’ AI-Designed Peptides: A Clinical Viability Report on Systemic Anti-Inflammatory and Anti-Fibrotic Agents

Sonia Rao December 10, 2025 No Comments

Chronic inflammation and fibrosis affect millions of people worldwide. Researchers estimate that fibrotic diseases contribute to up to 45 percent of global mortality. Because of this, there is growing urgency…

Author: Sonia Rao

Sign up to Get Latest Updates